Candriam Equities L Biotech.I-H EUR Acc/ LU1006082199 /
| NAV29/08/2024 | Chg.+2.3101 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 2,305.0200EUR | +0.10% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016 | -23.24 | -4.43 | 3.75 | 3.78 | 5.33 | -8.43 | 12.46 | -2.53 | 3.75 | -12.49 | 8.75 | -2.94 | -19.97% |
| 2017 | 5.35 | 6.80 | -0.20 | 1.09 | -3.22 | 9.15 | 2.42 | 6.37 | 0.68 | -6.52 | 0.12 | 1.45 | +24.87% |
| 2018 | 6.60 | -4.86 | -2.17 | -3.34 | 4.39 | 0.63 | 4.29 | 3.92 | -2.21 | -14.22 | 3.85 | -8.55 | -13.02% |
| 2019 | 12.85 | 3.33 | -0.81 | -5.08 | -4.94 | 9.21 | -2.52 | -2.51 | -4.38 | 10.29 | 11.72 | 2.21 | +30.43% |
| 2020 | -5.35 | -1.19 | -5.42 | 12.40 | 9.51 | 1.27 | -2.96 | 0.83 | 0.64 | -2.75 | 9.44 | 2.92 | +18.93% |
| 2021 | 1.81 | -2.57 | -4.35 | 2.71 | -2.27 | 6.35 | -1.45 | 3.89 | -4.27 | 0.17 | -4.38 | 2.32 | -2.71% |
| 2022 | -10.88 | -1.96 | 5.39 | -7.76 | -3.50 | 2.63 | 4.48 | 0.83 | -2.35 | 6.56 | 5.77 | -3.11 | -5.50% |
| 2023 | 2.75 | -5.94 | 0.32 | 2.02 | -1.38 | 1.02 | -0.32 | -0.34 | -4.46 | -6.26 | 5.71 | 13.23 | +4.95% |
| 2024 | 1.22 | 1.20 | -0.07 | -6.27 | 4.01 | 5.19 | 6.29 | 1.55 | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 16.36% | 16.55% | 17.23% | 20.05% | 22.57% |
| Sharpe ratio | 1.07 | 1.14 | 1.01 | -0.08 | 0.25 |
| Best month | +13.23% | +6.29% | +13.23% | +13.23% | +13.23% |
| Worst month | -6.27% | -6.27% | -6.27% | -10.88% | -10.88% |
| Maximum loss | -11.21% | -10.11% | -12.55% | -30.29% | -32.04% |
| Outperformance | +1.76% | - | +1.73% | -5.87% | +3.46% |
All quotes in EUR
Share classes
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Biotech.I-H ... | reinvestment | 2,305.0200 | +20.91% | +6.05% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,438.0300 | +20.71% | +21.51% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,690.5901 | +18.08% | +17.95% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 2,080.6599 | +24.64% | +17.83% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 242.1100 | +20.48% | +21.39% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 388.8500 | +18.97% | +22.29% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 358.1500 | +21.62% | +24.65% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 224.0100 | +18.79% | +4.26% | |
| Candriam Equities L Biotechnolog... | reinvestment | 167.0200 | - | - | |
| Candriam Equities L Biotech.N US... | reinvestment | 673.7300 | +22.79% | +12.67% | |
| Candriam Equities L Biotech.I US... | reinvestment | 6,330.1602 | +23.38% | +13.93% | |
| Candriam Equities L Biotechnolog... | reinvestment | 2,314.7100 | +23.53% | +14.34% | |
| Candriam Equities L Biotech.C-H ... | reinvestment | 220.8700 | +20.79% | +6.12% | |
| Candriam Equities L Biotech.R US... | reinvestment | 301.3700 | +24.33% | +16.95% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 230.8500 | +21.81% | +8.76% | |
| Candriam Equities L Biotechnolo... | reinvestment | 946.6600 | +23.24% | +14.07% | |
| Candriam Equities L Biotechnolog... | paying dividend | 864.4900 | +23.20% | +13.96% |
Performance
| YTD | +13.32% | ||
|---|---|---|---|
| 6 Months | +10.62% | ||
| 1 Year | +20.91% | ||
| 3 Years | +6.05% | ||
| 5 Years | +55.49% | ||
| 10 Years | - | ||
| Since start | +53.67% | ||
| Year | |||
| 2023 | +4.95% | ||
| 2022 | -5.50% | ||
| 2021 | -2.71% | ||
| 2020 | +18.93% | ||
| 2019 | +30.43% | ||
| 2018 | -13.02% | ||
| 2017 | +24.87% | ||
| 2016 | -19.97% | ||
